Supersulphides suppress type-I and type-II interferon responses by blocking JAK/STAT signalling in macrophages
International Immunology · 2024
DOI: 10.1093/intimm/dxae040 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, 2024. Verfasst von Xiaoyan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan. Hauptthemen laut MEDLINE: Signal Transduction, Macrophages, STAT1 Transcription Factor, Sulfides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, National Science Foundation, Ministry of Education, Science, Sports, and Technology.
Abstract (Originalsprache)
Interferons (IFNs) are cytokines produced and secreted by immune cells when viruses, tumour cells, and so forth, invade the body. Their biological effects are diverse, including antiviral, cell growth-inhibiting, and antitumour effects. The main subclasses of IFNs include type-I (e.g. IFN-α and IFN-β) and type-II (IFN-γ), which activate intracellular signals by binding to type-I and type-II IFN receptors, respectively. We have previously shown that when macrophages are treated with supersulphide donors, which have polysulphide structures in which three or more sulphur atoms are linked within the molecules, IFN-β-induced cellular responses, including signal transducer and activator of transcription 1 (STAT1) phosphorylation and inducible nitric oxide synthase (iNOS) expression, were strongly suppressed. However, the subfamily specificity of the suppression of IFN signals by supersulphides and the mechanism of this suppression are unknown. This study demonstrated that supersulphide donor N-acetyl-L-cysteine tetrasulphide (NAC-S2) can inhibit IFN signalling in macrophages stimulated not only with IFN-α/β but also with IFN-γ. Our data suggest that NAC-S2 blocks phosphorylation of Janus kinases (JAKs), thereby contributing to the inhibition of phosphorylation of STAT1. Under the current experimental conditions, the hydrogen sulphide (H2S) donor NaHS failed to inhibit IFN signalling. Similar to NAC-S2, the carbohydrate-based supersulphide donor thioglucose tetrasulphide (TGS4) was capable of strongly inhibiting tumour necrosis factor-α production, iNOS expression, and nitric oxide production from macrophages stimulated with lipopolysaccharide. Further understanding of the molecular mechanisms by which supersulphide donors exhibit their inhibitory actions towards JAK/STAT signalling is a necessary basis for the development of supersulphide-based therapeutic strategy against autoimmune disorders with dysregulated IFN signalling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
- Biobank center, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
- Department of Chemistry, Brown University, Providence, RI 02912, USA.
ORCID-Profile: Tomohiro Sawa
Förderung
- Japan Agency for Medical Research and Development
- National Science Foundation
- Ministry of Education, Science, Sports, and Technology
Zitieren
APA
Li, X., Toyomoto, T., Zhang, T., Guo, C., Lindahl, S., Tsutsuki, H., Xian, M., & Sawa, T. (2024). Supersulphides suppress type-I and type-II interferon responses by blocking JAK/STAT signalling in macrophages. International Immunology. https://doi.org/10.1093/intimm/dxae040
Vancouver
Li X, Toyomoto T, Zhang T, Guo C, Lindahl S, Tsutsuki H, et al. Supersulphides suppress type-I and type-II interferon responses by blocking JAK/STAT signalling in macrophages. International Immunology. 2024. doi:10.1093/intimm/dxae040
BibTeX
@article{Li2024,
author = {Li, Xiaoyan and Toyomoto, Touya and Zhang, Tianli and Guo, Chunyu and Lindahl, Stephen and Tsutsuki, Hiroyasu and Xian, Ming and Sawa, Tomohiro},
title = {Supersulphides suppress type-I and type-II interferon responses by blocking JAK/STAT signalling in macrophages},
journal = {International Immunology},
year = {2024},
doi = {10.1093/intimm/dxae040}
}
EUVIMED